Oklo Co-Founder in 200K pre-planned share sales
Oklo Inc. Co-Founder and COO Caroline Cochran reported pre-planned sales of 200,000 shares of Class A Common Stock on July 1, 2026.
Rhea-AI Filing Summary
Oklo Inc. Co-Founder and COO Caroline Cochran reported pre-planned sales of 200,000 shares of Class A Common Stock on July 1, 2026. The transactions, executed by GRATs, family trusts and spouse-related accounts, were open-market sales at prices around the low-to-mid $50s per share.
A Rule 10b5-1 trading plan adopted on March 31, 2025 governed the sales, indicating they were scheduled in advance. After the trades, reported positions remained sizable, including 536,483 shares in one Jacob DeWitte GRAT, 569,479 shares in a Caroline Cochran GRAT and 478,039 shares in an account reported as held by her spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 60,000 | $52.30 | $3.14M |
| Sale | Class A Common Stock | 40,000 | $53.28 | $2.13M |
| Sale | Class A Common Stock | 60,000 | $52.80 | $3.17M |
| Sale | Class A Common Stock | 40,000 | $53.71 | $2.15M |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (9)
- F1. The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted on March 31, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.52- $52.51 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3. For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.08- $53.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.51-$53.08 inclusive. The Reporting Person's spouse undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F6. For more information about the equity of the Issuer held by the Reporting Person's spouse, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- F7. Represents securities held by the Reporting Person's spouse.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.49-$54.30 inclusive. The Reporting Person's spouse undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F9. Represents securities beneficially owned by the Reporting Person's spouse.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
weighted average price financial
GRAT financial
beneficially owned financial
Class A Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Oklo (OKLO) report for Caroline Cochran?
Were the Oklo (OKLO) insider sales by Caroline Cochran pre-planned?
Does the Oklo (OKLO) Form 4 mention weighted average pricing for the insider trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.